• Home
  • Subscribe
  • Channels
      Acid RefluxAcneAcupunctureAddiction PreventionAesthetic MedicineAgricultureAllergiesAlzheimer’sAnimal HealthAnti-AgingArthritisAsthmaAutistic SyndromeAutoimmunityBeautyBeveragesBlood HealthBrain HealthBreast HealthBreastfeedingBullyingCancer InformationCancer PreventionCannabisCardiologyCaregiversCataract CareCBDCeliacCerebral PalsyCharityChildrens HealthChiropracticChronic IllnessConcierge MedicineCosmetic DentistryCosmetic DermatologyCOVID-19DatingDementiaDental CareDental ImplantsDepressionDermatologyDiabetesDigestiveDisinfectionDivorceDrug & Alcohol RehabilitationEating Disorder ChannelEbolaEducationeHealth Radio AustraliaElectromagnetic Fields (EMFs)Emergency CareEmotional HealthENTEpilepsyErectile DysfunctionEssential TremorEye HealthFamilyFemale HealthFeng ShuiFertilityFibromyalgiaFitnessFoot HealthFunctional MedicineGastrointestinal ChannelGERDGeriatricsGluten-FreeGynecologyHair HealthHair Loss PreventionHealthHealth & Wellness CoachingHealth CareHealth InsuranceHealth MarketingHealth NewsHearing HealthHeart BurnHeart DiseaseHeart HealthHip DysplasiaHormonal TherapyHospiceHygieneHyperbaric Oxygen TherapyHypnosisIn-Home CareIndigestionInfant HealthInfertilityIntegrative MedicineIrritable Bowel Syndrome (IBS)Kidney HealthLegal ChannelLife SupportLyme DiseaseMarriageMassage TherapyMemoryMenopauseMens HealthMental HealthMitochondriaMobile AppsMorgellons DiseaseMosquito RepellentsMoviesMultiple SclerosisNeurology ChannelNeuropathyNon-ProfitNonenalNutritionOnline DatingOpioidsOral HealthOrgan TransplantsOrthopedicOsteoarthritisOsteoporosisPain ManagementPalliative CareParentingPathogenic DiseasePediatricPelvic HealthPersonal DevelopmentPersonality DisordersPharmaceutical ChannelPhysical TherapyPlastic SurgeryPoison ControlPost Traumatic Stress DisorderPostpartum DepressionPostpartum RecoveryPR and MarketingPregnancyProbioticsProstate InformationPsoriasisPsychologyPsychotherapyPulmonaryPulmonary EmbolismRadiologyRare DiseasesRefluxRehabRehabilitationRelationshipsResearchRespiratory ChannelRetirementSafetyScoliosisSenior CareSexual HealthSkin CareSleepSleep ApneaSmartphone AppsSmoking CessationSocial AnxietySpa HealthSpecial NeedsSpinal Health ChannelStem Cell TherapyStress ManagementStroke RecoverySuicide PreventionSupplement ChannelSurgical AccessoriesTechnologyTelemedicineTelemental HealthTelenutritionTherapyTinnitusTraditional Chinese MedicineTravel Health CareTrichotillomaniaDefaultTagUrologyUV DisinfectionVascular BirthmarkVascular DiseaseVideo GamesWeight ManagementWhole-Body DonationWorkplaceWound CareYogaZika Virus
  • Profile
  1. All Episodes

Friday Oct 06, 2017

New Advances in the Development of a Viable Breast Cancer Vaccine

 

williams-william_pic.jpg

 

Dr. William Williams, CEO of BriaCell Therapeutics Corp., a company immuno-oncology focused biotechnology company developing a targeted and safe approach to the management of cancer joins eHealth Radio and the Cancer Information and Health News Channels. 

Listen to host Eric Michaels & guest Dr. William Williams discuss the following:

  • What is current standard of care today for breast cancer?  What are the limitations of these treatments?
  • How does this BriaVax work against late stage breast cancer?
  • How does a breast cancer vaccine such as BriaVax address recurrent breast cancer?
  • When will patients expect to be treated with a breast cancer vaccine.

 

Dr. William Williams is a seasoned biopharmaceutical executive with over 35 years of industry and academic expertise, including significant clinical management in multinational pharmaceutical companies. Dr. Williams served as VP of Exploratory Development at Incyte Corporation from 2005 - 2016. There he facilitated entry of over 20 compounds into the clinic, including ruxolitinib (Jakafi), baricitinib, and epacadostat.

Dr. Williams served as Head of Rheumatology Research at the University of Pennsylvania, ran a major research program in receptor biology, including developing bioactive peptides that mimicked granulocyte-macrophage colony-stimulating factor (GM-CSF), a known stimulant of the immune system. He collaborated with David B. Weiner, Ph.D., a well-known leader in immuno-oncology and vaccine research, in the development of DNA vaccines and was able to bring novel DNA vaccines into the clinic for the treatment of cutaneous T cell lymphoma.

Dr. Williams earned his BSc. in Chemistry and Biotechnology from Massachusetts Institute of Technology and Medical Doctorate from Tufts University School of Medicine. Following his residency at the Boston VA Medical Center, Dr. Williams completed fellowship training in Rheumatology and Cellular Immunology at the University of Missouri. He then joined the molecular immunology laboratory of Mark I. Greene, MD, PhD, FRCP, at the University of Pennsylvania, developed novel methods of bioactive peptide design, and collaborated in the study of the activation of the p185/Human epidermal growth factor receptor 2 (HER2) receptor. HER-2 is a protein which is known to promote the growth of cancer cells. Dr. Williams is the named author at over 130 peer reviewed publications, over 15 patents and numerous Investigational New Drugs (INDs) and NDAs.

 

BriaCELL_logo_V4_1-Final_-_Copy_1_.jpg

 

Website: www.briacell.com

  • Download

Comments (0)

To leave or reply to comments, please download free Podbean or

No Comments

To leave or reply to comments,
please download free Podbean App.

iOS appAndroid app

Copyright 2010 - 2022 eHealth Radio Network. All rights reserved.

Podcast Powered By Podbean